Mymetics Corporation (MYMX)
OTHER OTC:MYMX

Mymetics (MYMX) Stock Price & Analysis

11 Followers

MYMX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.08
Previous Close$0.01
Volume2.70K
Average Volume (3M)145.49K
Market Cap
$2.64M
Enterprise Value$2.57M
Total Cash (Recent Filing)€335.00K
Total Debt (Recent Filing)€265.00K
Price to Earnings (P/E)-0.5
Beta0.69
May 14, 2018
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding303,757,622
10 Day Avg. Volume22,800
30 Day Avg. Volume145,487
Standard Deviation0.28
R-Squared0.00131
Alpha-0.00037
Financial Highlights & Ratios
Price to Book (P/B)-0.03
Price to Sales (P/S)9.54
Price to Cash Flow (P/CF)30.70
P/FCF Ratio0.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

MYMX FAQ

What was Mymetics Corporation’s price range in the past 12 months?
Mymetics Corporation lowest stock price was <$0.01 and its highest was $0.07 in the past 12 months.
    What is Mymetics Corporation’s market cap?
    Currently, no data Available
    When is Mymetics Corporation’s upcoming earnings report date?
    Mymetics Corporation’s upcoming earnings report date is May 14, 2018 which is 1842 days ago.
      How were Mymetics Corporation’s earnings last quarter?
      Currently, no data Available
      Is Mymetics Corporation overvalued?
      According to Wall Street analysts Mymetics Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Mymetics Corporation pay dividends?
        Mymetics Corporation does not currently pay dividends.
        What is Mymetics Corporation’s EPS estimate?
        Mymetics Corporation’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Mymetics Corporation have?
        Mymetics Corporation has 303,757,630 shares outstanding.
          What happened to Mymetics Corporation’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Mymetics Corporation?
          Currently, no hedge funds are holding shares in MYMX

          ---

          Mymetics Stock Smart Score

          N/A
          Not Ranked
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Fundamentals

          Return on Equity
          Trailing 12-Months
          Asset Growth
          -5.14%
          Trailing 12-Months
          This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
          Learn more about TipRanks Smart Score

          Company Description

          Mymetics Corporation

          Mymetics Corp. is a biotechnology company, which engages in the research and development of virosome based vaccines. It focuses on next generation vaccines for infectious and life disabling diseases. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland.

          ---

          Forecast EPS vs Actual EPS


          Similar Stocks
          Company
          Price & Change
          Follow
          ObsEva
          Crispr Therapeutics AG
          ADC Therapeutics
          AC Immune SA

          Popular Stocks

          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis